{"slug":"genetics","tag":"genetics","variants":["genetics"],"description":"No description yet","count":4,"kinds":{"person":4},"related":[{"slug":"leadership","tag":"leadership","shared":3},{"slug":"clinician-scientist","tag":"clinician-scientist","shared":2},{"slug":"breast","tag":"breast","shared":1},{"slug":"dermatology","tag":"dermatology","shared":1},{"slug":"paediatric-oncology","tag":"paediatric oncology","shared":1},{"slug":"paediatrics","tag":"paediatrics","shared":1},{"slug":"trialist","tag":"trialist","shared":1}],"records":[{"id":"ronald-cohn","kind":"person","name":"Ronald Cohn","route":"/people/ronald-cohn/","tldr":"Clinical geneticist who leads The Hospital for Sick Children in Toronto, one of the world's largest paediatric academic health centres."},{"id":"eli-sprecher","kind":"person","name":"Eli Sprecher","route":"/people/eli-sprecher/","tldr":"Dermatologist and geneticist who has been chief executive of Tel Aviv Sourasky Medical Center, a major Israeli academic hospital, since 2024."},{"id":"brandon-wainwright","kind":"person","name":"Brandon Wainwright","route":"/people/brandon-wainwright/","tldr":"Geneticist known for work on the genetic drivers of childhood brain cancer who became Director and CEO of QIMR Berghofer, a leading Australian medical research institute, in 2026."},{"id":"mark-robson","kind":"person","name":"Mark E. Robson","route":"/people/mark-robson/","tldr":"New York breast oncologist and cancer geneticist who led OlympiAD, the trial that made olaparib the first PARP inhibitor approved for BRCA-mutated breast cancer."}]}